Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Mendels.
Clinical management of the depressed geriatric patient: current therapeutic options.
Am J Med, 94 (1993), pp. 13-18
[2.]
H.G. Koenig, D.G. Blazer, L.B. Hocking, et al.
Depression, anxiety and other affective disorders.
Geriatric medicine, 3.a, pp. 949-965
[3.]
NIH Consensus Panel on Diagnosis and Treatment of Depression in Late Life.
Diagnosis and treatment of depression in late life.
JAMA, 268 (1992), pp. 1018-1024
[4.]
Reynolds CF III.
Treatment of depression in late life.
Am J Med, 97 (1994), pp. 39-46
[5.]
J.R. Shua-Haim, M.R. Sabo, E. Comsti, J.S. Gross.
Depression in the Elderly.
Hospital Medicine, 33 (1997), pp. 45-58
[6.]
H.G. Koenig, K.G. Meador, F. Shelp.
Depressive disorders in hospitalized medically ill patients: a comparison of young and elderly men.
J Am Geriatr Soc, 39 (1991), pp. 881-890
[7.]
P.A. Parmelee, I.R. Katz, M.P. Lawton.
Depression among institutionalized elderly: assessment and prevalence estimation.
J Gerontology, 44 (1989), pp. 22-26
[8.]
M. Cid Sanz.
Síndrome depresivo. En: Grandes síndromes geriátricos. Programa de Formación Continuada en Geriatría para Médicos de Atención Primaria. Tercera unidad didáctica.
[9.]
B.D. Lebowitz, J.L. Pearson, L.S. Schneider, I.I.I. Reynolds CF, G.S. Alexopoulos, M.L. Bruce, et al.
Actualización y tratamiento de la depresión en los ancianos. JAMA (ed.
esp.), 7 (1998), pp. 162-167
[10.]
H.G. Koenig, D.G. Blazer.
Epidemiology of geriatric affective disorders.
Clin Geriatr Med, 8 (1992), pp. 235-251
[11.]
M.V. Zunzunegui, F. Beland, A. Llácer.
León V. Gender differences in depressive symptoms among Spanish elderly.
Soc Psychiatry Psychiatr Epidemiol, 33 (1998), pp. 195-205
[12.]
D.G. Blazer, D.C. Hughes, L.K. George.
The epidemiology of depression in an elderly community population.
Gerontologist, 27 (1987), pp. 281-287
[14.]
B.D. Bair.
Frequently missed diagnosis in geriatric psychiatry.
Psychiatr Clin North Am, 21 (1998), pp. 941-971
[15.]
M.A. Raskind.
Geriatric psychopharmacology.
Psychiatric Clin North Am, 16 (1993), pp. 815-827
[16.]
Reynolds CF III.
Depresión: diagnóstico y tratamiento con inhibidores de la recaptación de la serotonina.
Modern Geriatrics, 9 (1997), pp. 63-68
[17.]
B.S. Meyers.
Geriatric depression.
Curr Opin Psychiatry, 7 (1994), pp. 337-341
[18.]
J.G. Koenig, H.J. Cohen, D.G. Blazer, K.R.R. Krishnan, T.E. Siber.
Profile of depressive symptoms in younger and older inpatients with major depression.
J Am Geriatr Soc, 49 (1993), pp. 1169-1176
[19.]
D. Blazer.
Depression in the elderly.
N Engl J Med, 320 (1989), pp. 164-166
[20.]
D.G. Blazer.
Depression in the elderly.
Hosp Pract, 18 (1994), pp. 37-44
[21.]
Katona CLE.
Tratando la depresión en el anciano.
Inhibidores selectivos de la recaptación de serotonina, 2.a, pp. 187-215
[22.]
B.S. Greenwald, E. Kramer-Ginsberg, K.R. Krishnan, M. Ashtari, C. Auerbach, M. Patel.
Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression.
Stroke, 29 (1998), pp. 613-617
[23.]
N. Hirono, E. Mori, K. Ishii, Y. Ikejiri, T. Imamura, T. Shimomura, et al.
Frontal lobe hypometabolism and depression in Alzheimer's disease.
Neurology, 50 (1998), pp. 380-383
[24.]
G.S. Alexopoulos, B.S. Meyers, R.C. Young, T. Kakuma, D. Silbersweig, M. Charlson.
Clinically defined vascular depression.
Am J Psychiatry, 154 (1997), pp. 562-565
[25.]
DSM-IV.
Manual diagnóstico y estadístico de las enfermedades mentales.
[26.]
C. Tannock, C. Katona.
Minor depression in the aged: concepts, prevalence and optimal management.
Drugs Aging, 6 (1995), pp. 278-292
[27.]
G.S. Alexopoulos, R.C. Young, B.S. Meyers.
Late-onset depression.
Psychiatr Clin North Am, 11 (1988), pp. 101-115
[28.]
L.S. Schneider.
Psychobiologic features of geriatric affective disorder.
Clin Geriatr Med, 8 (1992), pp. 253-265
[29.]
E.J.L. Finch, R. Ramsay, C.L.E. Katona.
Depression and physical illness in the elderly.
Clin Geriatr Med, 8 (1992), pp. 275-287
[30.]
S.R. Rapp, K.M. Davis.
Geriatric depression: physicians' knowledge, perceptions, and medical admissions.
Gerontologist, 29 (1989), pp. 252-257
[31.]
J. Yesavage.
Differential diagnosis between depression and dementia.
Am J Med, 94 (1993), pp. 23-28
[32.]
I.R. Katz.
On the inseparability on mental and physical health in aged persons: lessons from depression and medical comorbidity.
Am J Geriatr Psychiatry, 4 (1996), pp. 1-16
[33.]
E.J. Pérez-Stable, J. Miranda, R.F. Muñoz, Y.W. Ying.
Depression in medical outpatients.
Arch Intern Med, 150 (1990), pp. 1083-1088
[34.]
H.G. Koenig, F. Shelp, G. Veeraindar.
Survival and health care utilization in elderly medical inpatients with major depression.
J Am Geriatr Soc, 37 (1989), pp. 599-606
[35.]
B.S. Meyers, G.S. Alexopoulos.
Geriatric depression.
Med Clin North Am, 72 (1988), pp. 847-866
[36.]
T.A. Badger.
Depression, physical health impairment and service use among older adults.
Public Health Nurs, 15 (1998), pp. 136-145
[37.]
J. Ormel, G.I. Kempen, D.J. Deeg, E.I. Brilman, E. Van Sonderen, J. Relyveld.
Functioning, well-being, and health perception in late middle-aged and older people: comparing the effects of depressive symptoms and chronic medical conditions.
J Am Geriatr Soc, 46 (1998), pp. 39-48
[38.]
U. Skerritt, R. Evans, S.A. Montgomery.
Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.
Drugs Aging, 10 (1997), pp. 209-218
[39.]
S.I. Kramer, B.V. Reifler.
Depression, dementia, and reversible dementia.
Clin Geriatr Med, 8 (1992), pp. 289-297
[40.]
K. Ritchie, J. Touchon, B. Ledesert.
Progressive disability in senile dementia is accelerated in the presence of depression.
Int J Geriatr Psychiatry, 13 (1998), pp. 459-461
[41.]
G.S. Alexopoulos, B.S. Meyers, R.C. Young, S. Mattis, T. Kakuma.
The course of geriatric depression with reversible dementia.
Am J Psychiatry, 150 (1993), pp. 1693-1699
[42.]
D.G. Blazer, J.R. Bachar, K.G. Manton.
Suicide in late life: review and commentary.
J Am Geriatr Soc, 34 (1986), pp. 519-525
[43.]
H. Catell, D.J. Holey.
One hundred cases of suicide in elderly people.
Br J Psychiatry, 166 (1995), pp. 451-457
[44.]
C.M. Callahan, H.C. Hendrie, N.A. Nienaber, W.M. Tierney.
Suicidal ideation among older primary care patients.
J Am Geriatr Soc, 44 (1996), pp. 1205-1209
[45.]
J.A. Yesavage, T.L. Brink, T.L. Rose, O. Lum, V. Huang, M. Adey, et al.
Development and validation of a geriatric depression screening scale: a preliminary report.
J Psychiatr Res, 17 (1983), pp. 37-49
[46.]
P. D'Ath, P. Katona, M. Mullan, S. Evans, C. Katona.
Screening, detection and management of depression in elderly primary care attenders. 1: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS 15) and the development of short versions.
Family Practice, 11 (1994), pp. 260-266
[47.]
J.I. Sheikh, J.A. Yesavage.
Geriatric depression scale (GDS): recent evidence and development of a shorter version.
Clin Gerontologist, 5 (1986), pp. 165-173
[48.]
H. Brodaty, L. Harris, K. Peters, I. Wilhelm, P. Hickie, P. Boyce, et al.
Prognosis of depression in the elderly. A comparison with younger patients.
Br J Psychiatry, 163 (1993), pp. 589-596
[50.]
R.E. McCue.
Using tryciclic antidepressants in the elderly.
Clin Geriatr Med, 8 (1992), pp. 323-334
[51.]
I.I.I. Reynolds CF, E. Frank, J.M. Perel, S.D. Imber, C. Cornes, M.D. Miller, et al.
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression.
JAMA, 281 (1999), pp. 39-45
[52.]
H.G. Koenig, V. Goli, F. Shelp.
Major depression in hospitalized medically ill men: documentation, treatment, and prognosis.
Int J Geriatr Psychiatry, 7 (1992), pp. 25-34
[53.]
R.C. Baldwin, D.J. Jolley.
The prognosis of depression in old age.
Br J Psychiatry, 149 (1986), pp. 574-580
[54.]
E. Murphy.
The prognosis of depression in old age.
Br J Psychiatry, 142 (1983), pp. 111-119
[55.]
G.S. Alexopoulos, J.G. Chester.
Outcomes of geriatric depression.
Clin Geriatr Med, 8 (1992), pp. 363-375
[56.]
B.W. Rovner.
Depression and increased risk of mortality in the nursing home patient.
Am J Med, 94 (1993), pp. 19-22
[57.]
S.K. Rigler, S. Studenski, P.W. Duncan.
Pharmacologic treatment of geriatric depression: Key issues in interpreting the evidence.
J Am Geriatr Soc, 46 (1998), pp. 106-110
[58.]
K.B. Wells, A. Stewart, R.D. Hays, A. Burnam, W. Rogers, M. Daniel, et al.
The functioning and well-being of depressed patients: results from the Medical Outcomes Study.
JAMA, 262 (1989), pp. 914-919
[59.]
J.M. Lyness, E.D. Caine, Y. Conwell, D.A. King, C. Cox.
Depressive symptoms, medical illness and functional status in depressed psychiatric inpatients.
Am J Psychiatry, 150 (1993), pp. 910-915
[60.]
B.W. Penninx, J.M. Guralnik, L. Ferrucci, M. Simonsick, D.J. Deeg, R.B. Wallace.
Depressive symptoms and physical decline in community-dwelling older persons.
JAMA, 279 (1998), pp. 1720-1726
[61.]
D.L. Musselman, D.L. Evans, C.B. Nemeroff.
The relationship of depression to cardiovascular disease.
Arch Gen Psychiatry, 55 (1998), pp. 580-592
[62.]
R.M. Glass.
Treating depression as a recurrent or chronic disease [editorial].
JAMA, 281 (1999), pp. 83-84
[63.]
L. Fredman, J. Magaziner, J.R. Hebel, W. Hawkes, S.I. Zimmerman.
Depressive symptoms and 6-year mortality among elderly community-dwelling women.
Epidemiology, 10 (1999), pp. 54-59
[64.]
J.E.A. Menting, A. Honig, F.R.J. Verhey, M. Hartmans, M. Rozendaal, HCW De Vet, et al.
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
Int Clin Psychopharmacol, 11 (1996), pp. 165-175
[65.]
K. Anstey, H. Brodaty.
Antidepressants and the elderly: double-blind trials 1987-1992.
Int J Geriatr Psychiatry, 10 (1995), pp. 265-279
[66.]
J. McCusker, M. Cole, E. Keller, F. Bellavance, A. Berard.
Effectiveness of treatments of depression in older ambulatory patients.
Arch Intern Med, 158 (1998), pp. 705-712
[67.]
A.J. Flint.
Choosing appropriate antidepressant therapy in the elderly.
Drugs Aging, 13 (1998), pp. 269-280
[68.]
N. Mittmann, N. Herrmann, T.R. Einarson.
The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.
J Affect Disord, 46 (1997), pp. 191-217
[69.]
C. Salzman.
Pharmacologic treatment of depression in the elderly.
J Clin Psychiatry, 54 (1993), pp. 23-28
[70.]
S.I. Finkel.
Efficacy and tolerability of antidepressant therapy in the old-old.
J Clin Psychiatry, 57 (1996), pp. 23-28
[71.]
D.G. Blazer.
Síndromes depresivos en geriatría.
[72.]
S.P. Roose, A.H. Glassman, E. Attia, S. Woodring.
Comparative efficacy of SSRI and tricyclics in the treatment of melancholia.
Am J Psychiatry, 151 (1994), pp. 1735-1739
[73.]
S.H. Preskorn.
Recent pharmacologic advances in antidepressant therapy for the elderly.
Am J Med, 94 (1993), pp. 2-12
[74.]
J.M. Davis, A.H. Glassman.
Antidepressant drugs.
Comprehensive textbook of psychiatry, 5.a, pp. 1627-1655
[75.]
L. Nolan, K. O'Malley.
Adverse effects of antidepressants in the elderly.
Drugs Aging, 2 (1992), pp. 450-458
[76.]
J.P. Halper, J.J. Mann.
Cardiovascular effects of antidepressant medications.
Br J Psychiatry, 153 (1988), pp. 87-98
[77.]
J.C. Nelson.
Current status of tricyclic antidepressants in psychiatry: their pharmacology and clinical applications.
J Clin Psychiatry, 52 (1991), pp. 193-200
[78.]
P.S. Aisen.
Medical evaluation of the elderly psychiatric patient.
Mount Sinai J Med, 58 (1991), pp. 85-90
[79.]
R.J. Cadieux.
Geriatric psychopharmacology. A primary care challenge.
Postgrad Med, 93 (1993), pp. 281-301
[80.]
D.P. Hay, M.M. Rodríguez, K.L. Franson.
Treatment of depression in late life.
Clin Geriatr Med, 14 (1998), pp. 33-46
[81.]
C. Salzman.
Monoamine oxidase inhibitors and atypical antidepressants.
Clin Geriatr Med, 8 (1992), pp. 335-348
[83.]
P. Pancheri, R. Delle Chiaie, M. Donnini, S. Seripa, C. Gambino, E. Vicario, et al.
Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: A controlled comparative study versus imipramine.
Clin Neuropharmacol, 17 (1994), pp. 58-73
[84.]
J. Angst, M. Stabl.
Efficacy of moclobemide in different patient groups: a metaanalysis of studies.
Psychopharmacology, 106 (1992), pp. 109-113
[85.]
I.F. Tulloch, A.M. Johnson.
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
J Clin Psychiatry, 53 (1992), pp. 7-12
[86.]
C.K. Cohn, R. Shrivastava, J. Mendels, J.B. Cohn, L.F. Fabre, J.L. Claghorn, et al.
Double-blind, multicenter comparison of sertraline and amitryptiline in elderly depressed patients.
J Clin Psychiatry, 51 (1990), pp. 28-33
[87.]
D.L. Dunner, J.B. Cohn, III Walshe T, C.K. Cohn, J.P. Feighner, R.R. Fieve, et al.
Two combined, multicenter doubleblind studies of paroxetine and doxepine in geriatric patients with major depression.
J Clin Psychiatry, 53 (1992), pp. 57-60
[88.]
J.P. Feighner, W.F. Boyer, C.H. Meredith, G. Hendrickson.
An overview of fluoxetine in geriatric depression.
Br J Psychiatry, 153 (1988), pp. 105-108
[89.]
G.L. Cooper.
The safety of fluoxetine: an update.
Br J Psychiatry, 153 (1988), pp. 77-86
[90.]
L.S. Gram.
Fluoxetine.
N Engl J Med, 331 (1994), pp. 1354-1361
[91.]
W.F. Boyer, J.P. Feighner.
Seguridad y tolerancia de los inhibidores selectivos de la recaptación de serotonina.
Inhibidores selectivos de la recaptación de serotonina, 2.a, pp. 311-334
[92.]
M.D. Llorente, M. Gorelick, M.A. Silverman.
Sertraline as a cause of inappropiate antidiuretic hormone secretion.
J Clin Psychiatry, 55 (1994), pp. 543-544
[93.]
S. Hussein, B.N. Kaufman.
Bradycardia associated with fluoxetine in an elderly patient with sick sinus syndrome.
Postgrad Med J, 70 (1994), pp. 56
[94.]
A.L. Nyth, C.G. Gottfries.
The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study.
Br J Psychiatry, 157 (1990), pp. 894-901
[95.]
A.J. Flint, J. Crosby, J.L. Genik.
Recurent hyponatremia associated with fluoxetine and paroxetine [carta].
Am J Psychiatry, 153 (1996), pp. 134
[96.]
I. Hindmarch, J. Shillingford, C. Shillingford.
The effects of sertraline on psychomotor performance in elderly volunteers.
J Clin Psychiatry, 12 (1990), pp. 34-36
[97.]
Y.I. Sheline, K.E. Freedland, R.M. Carney.
How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?.
Am J Med, 102 (1997), pp. 54-59
[98.]
S.P. Roose, F. Laghrissi-Thode, J.S. Kennedy, J.C. Nelson, J.T. Bigger Jr, B.G. Pollock, et al.
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
JAMA, 279 (1998), pp. 287-291
[99.]
F. Song, N. Freemantle, T.A. House, P. Watson, A. Long.
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
BMJ, 306 (1993), pp. 683-687
[100.]
L. Waintraub.
La depression du sujet agé: reconnaissance et traitment.
Presse-Med, 27 (1998), pp. 2129-2144
[101.]
J. Avorn.
Depression in the elderly -Falls and pitfalls [editorial].
N Engl J Med, 339 (1998), pp. 918-920
[102.]
W.F. Boyer, J.P. Feighner.
Utilización práctica de los inhibidores selectivos de la recaptación de serotonina.
Inhibidores selectivos de la recaptación de serotonina, 2.a, pp. 335-347
[103.]
K. Brosen, B.B. Rasmussen.
Inhibidores selectivos de la recaptación de serotonina: farmacocinética e interacciones farmacológicas.
Inhibidores selectivos de la recaptación de serotonina, 2.a, pp. 93-114
[104.]
C.A. Orengo, M.E. Kunik, V. Molinari, R.H. Workman.
The use and tolerability of fluoxetine in geropsychiatric inpatients.
J Clin Psychiatry, 57 (1996), pp. 12-16
[105.]
G.C. Dunbar.
Paroxetine in the elderly: a comparative metanalysis against standard antidepressant pharmacotherapy.
Pharmacology, 51 (1995), pp. 137-144
[106.]
C.L. Corby.
Paroxetine: a review.
J Serotonin Res, 4 (1997), pp. 47-64
[107.]
S.H. Preskorn.
Pharmacokinetics of antidepressants: why and how is it relevant for treatment?.
J Clin Psychiatry, 54 (1993), pp. 14-34
[108.]
M.I. Wilde, G.I. Plosker, P. Benfield.
Fluvoxamine. An update review of its pharmacology, and therapeutic use in depressive illness.
Drugs, 46 (1993), pp. 895-924
[109.]
P. Benfield, A. Ward.
Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Drugs, 32 (1986), pp. 313-334
[110.]
W. Wagner, B. Plekkenpol, T.E. Gray, H. Vlaskamp, H. Essers.
Review of fluvoxamine safety database.
Drugs, 43 (1992), pp. 48-54
[111.]
J.P. Feighner.
The role of venlafaxine in rational antidepressant therapy.
J Clin Psychiatry, 55 (1994), pp. 62-68
[112.]
E. Richelson.
Pharmacology of antidepressants -characteristics of the ideal drug.
Mayo Clin Proc, 69 (1994), pp. 1069-1081
[113.]
J.r. Beasley CM, B.E. Dornseif, J.A. Pultz, J.C. Bosomworth, M.E. Sayler.
Fluoxetine versus trazodone: efficacy and activating-sedating effects.
J Clin Psychiatry, 52 (1991), pp. 294-299
[114.]
M.W. Van Laar, A.P.P. Van Willigenburg, E.R. Volkerts.
Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adults and elderly subjects.
J Clin Psychopharmacol, 15 (1995), pp. 30-40
[115.]
M.L. Montejo Iglesias.
Papel actual del empleo de psicoestimulantes en los trastornos afectivos.
Farmacología SNC, 7 (1993), pp. 18-27
[116.]
L.W. Lazarus, P.J. Moberg, P.R. Langsley.
Methylphenydate and nortryptiline in the treatment of post-stroke depression: a retrospective comparison.
Arch Phys Med Rehab, 75 (1994), pp. 403-406
[117.]
C. Hartman, L.W. Lazarus.
Psychotherapy with elderly depressed patients.
Clin Geriatr Med, 8 (1992), pp. 355-362
[118.]
S.J. Kantor.
Depression: when is psychotherapy not enough?.
Psychiatr Clin North Am, 13 (1990), pp. 241-254
[119.]
R.G. Morris, I.W. Morris.
Cognitive and behavioural approaches with the depressed elderly.
Int J Geriatr Psychiatry, 6 (1991), pp. 407-413
[120.]
L. Greenberg, M. Fink.
The use of electroconvulsive therapy in geriatric patients.
Clin Geriatr Med, 8 (1992), pp. 349-354
[121.]
S.M. Benbow.
The role of electroconvulsive therapy in the treatment of depressive illness in old age.
Br J Psychiatry, 155 (1989), pp. 147-152
[123.]
A.M. Wilkinson, D.N. Anderson, S. Peters.
Age and the effects of ECT.
Int J Geriatr Psychiatry, 8 (1993), pp. 401-406
[124.]
D.P. Devanand, R.B. Krueger.
Electroconvulsive therapy in the elderly.
Curr Opin Psychiatry, 7 (1994), pp. 359-364
[125.]
R.J. Zielinski, S.P. Roose, D.P. Devanand, S. Woodring, H.A. Sackeim.
Cardiovascular complications of ECT in depressed patients with cardiac disease.
Am J Psychiatry, 150 (1993), pp. 904-909
[126.]
W.R. Dubin, R. Jaffe, R. Roemer, L. Siegel, B. Shoyer, M.L. Venditti.
The efficacy and safety of maintenance ECT in geriatric patients.
J Am Geriatr Soc, 40 (1992), pp. 706-709
[127.]
I.I.I. Reynolds CF, E. Frank, D.J. Kupfer, M.E. Thase, J.M. Perel, S. Mazumdar, et al.
Treatment outcomes in recurrent major depression: a post hoc comparison of elderly («young old») and midlife patients.
Am J Psychiatry, 153 (1996), pp. 1288-1292
[128.]
Old Age Depression Interest Group.
How long should the elderly take antidepressants?.
Br J Psychiatry, 162 (1993), pp. 175-182
[129.]
S.A. Montgomery.
Inhibidores selectivos de la recaptación de serotonina en el tratamiento de la depresión a largo plazo.
Inhibidores selectivos de la recaptación de serotonina, 2.a, pp. 127-140
[130.]
J.F. Greden.
Antidepressant maintenance medications: when to discontinue and how to stop.
J Clin Psychiatry, 54 (1993), pp. 39-45
[131.]
D. Ames, N. Allen.
The prognosis of depression in old age: good, bad or indifferent?.
Int J Geriatr Psychiatry, 6 (1991), pp. 477-481
[132.]
WHO Mental Health Collaborating Centres.
Pharmacotherapy of depressive disorders. A consensus statement.
J Affect Disord, 17 (1995), pp. 197-198
[133.]
D.L. Dunner.
Therapeutic considerations in treating depression in the elderly.
J Clin Psychiatry, 55 (1994), pp. 48-58
[134.]
M.B. Keller, J.H. Kocsis, M.E. Thase, A.J. Gelenberg, A.J. Rush, L. Koran, et al.
Maintenance phase efficacy of sertraline for chronic depression.
JAMA, 280 (1998), pp. 1665-1672
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
